Lyu, P., Ge, L., Ma, R., Wei, R., McCrudden, C. M., Chen, T., . . . Kwok, H. F. (2018). Identification and pharmaceutical evaluation of novel frog skin-derived serine proteinase inhibitor peptide–PE-BBI (Pelophylax esculentus Bowman-Birk inhibitor) for the potential treatment of cancer. Nature Portfolio.
Cita Chicago Style (17a ed.)Lyu, Peng, Lilin Ge, Rui Ma, Ran Wei, Cian M. McCrudden, Tianbao Chen, Chris Shaw, y Hang Fai Kwok. Identification and Pharmaceutical Evaluation of Novel Frog Skin-derived Serine Proteinase Inhibitor Peptide–PE-BBI (Pelophylax Esculentus Bowman-Birk Inhibitor) for the Potential Treatment of Cancer. Nature Portfolio, 2018.
Cita MLA (8a ed.)Lyu, Peng, et al. Identification and Pharmaceutical Evaluation of Novel Frog Skin-derived Serine Proteinase Inhibitor Peptide–PE-BBI (Pelophylax Esculentus Bowman-Birk Inhibitor) for the Potential Treatment of Cancer. Nature Portfolio, 2018.